Monopar Therapeutics Overview
Monopar Therapeutics Target Price
Analysts' 12-month price predictions for MNPR.
Get informed when a big investor buys or sells
+ FollowShare Price
$61.47
Average Target Price
$105.00
70.8% upside
70.8% upside1 analysts in the last 4 months
High: $105 | Low: $105
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-02 | Piper Sandler | $105 | 70.8% upside |  |
| 2026-01-09 | Morgan StanleyMaxwell Skor | $115 | 87.1% upside | |
| 2025-11-14 | Raymond JamesChris Raymond | $123 | 100.1% upside | |
| 2025-10-13 | BarclaysEtzer Darout | $125 | 103.4% upside | |
| 2025-10-06 | Raymond James | $142 | 131% upside | |
| 2025-10-02 | Oppenheimer | $115 | 87.1% upside | |
| 2025-09-29 | H.C. Wainwright | $105 | 70.8% upside | |
| 2025-09-25 | Piper SandlerBiren Amin | $95 | 54.5% upside | |
| 2025-09-25 | Chardan CapitalKeay Nakae | $85 | 38.3% upside | |
| 2025-09-24 | BTIG | $104 | 69.2% upside | |
| 2025-09-09 | BTIGJeet Mukherjee | $87 | 41.5% upside | |
| 2025-09-02 | Raymond James | $80 | 30.1% upside | |
| 2025-08-26 | H.C. Wainwright | $70 | 13.9% upside | |
| 2024-11-19 | UBSJustin Walsh | $37 |  39.8% downside | |
| 2024-11-11 | H.C. WainwrightSean Lee | $22 | 64.2% downside | |